(Q40430439)

20 September 2017

1 reference

title

Angiotensin-converting enzyme inhibitors post-myocardial infarction (English)

1 reference

20 September 2017

Angiotensin-Converting Enzyme Inhibitors Post-Myocardial Infarction (English)

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

25 May 2024

author name string

J. B. Young

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585774

25 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7585774

25 May 2024

publication date

1 August 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:S0733865118300365?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

https://api.elsevier.com/content/article/PII:S0733865118300365?httpAccept=text/plain

25 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

25 May 2024

1 reference

20 September 2017

volume

13

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

379-390

1 reference

ACE inhibitors--a cornerstone of the treatment of heart failure

20 September 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction

25 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

25 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

25 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

The prevention of heart failure--a new agenda

25 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

25 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

25 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

ACE inhibition: benefits beyond blood pressure control

25 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Renin and myocardial infarction in hypertension

25 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography

25 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

25 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

The heart in hypertension

25 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina

25 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction

25 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Infarct expansion versus extension: two different complications of acute myocardial infarction

25 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation

25 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina

25 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure

25 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

25 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

25 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

25 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

25 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators

25 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

The effect of diltiazem on mortality and reinfarction after myocardial infarction

25 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

A potent genetic risk factor for restenosis

25 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

25 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

25 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy

25 May 2024

41

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

25 May 2024

42

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus

25 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

25 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction

25 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

25 May 2024

46

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

25 May 2024

47

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction

25 May 2024

48

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Suppressive effect of captopril on platelet aggregation in essential hypertension

25 May 2024

49

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

25 May 2024

50

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

25 May 2024

51

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction

25 May 2024

52

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498

25 May 2024

53

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials

25 May 2024

54

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials

25 May 2024

55

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

25 May 2024

56

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30036-5

25 May 2024

Identifiers

1 reference